Remote Alcohol Monitoring to Facilitate Abstinence From Alcohol: Exp 2
Running, not enrolling · Not applicable · Has a placebo group
Conditions studied: Alcohol Use Disorder
In brief
Directly reinforcing abstinence from alcohol with monetary incentives is an effective treatment for alcohol dependence, but barriers in obtaining frequent, verified biochemical measures of abstinence limit the dissemination of this treatment approach. As our feasibility study demonstrates, remote breathalyzer monitoring drastically improves the practicality of delivering an alcohol contingency management intervention. In Experiment 2, we will test whether the addition of remote abstinence incentives to treatment as usual improves outpatient treatment outcomes and prevents relapse following inpatient detoxification at a regional hospital system. We will also assess whether readmission rates are reduced using a newly developed smartphone app and breathalyzer.
Key facts
- Study ID
- NCT03942770
- Run by
- Mikhail N Koffarnus
- People needed
- 91
- Starts
- 2019-07-15
- Expected to finish
- 2026-08-31
- Last updated by the study team
- 2026-04-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Recently completed or currently completing an alcohol detoxification program through the Carilion Clinic or University of Kentucky Healthcare system.
- Meet DSM-V criteria for alcohol use disorder.
- Abstinent from alcohol at the time of consent.
You may not qualify if…
- Alcohol use disorder is secondary to another substance use disorder.
Where it is running
- University of Kentucky Healthcare — Lexington, Kentucky, United States
- Virginia Tech Carilion — Roanoke, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.